Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Timmermans MM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kortleve D; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Hammerl D; Pan Cancer T BV, Rotterdam, Netherlands., van Brakel M; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Wijers R; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Roelofs D; Pan Cancer T BV, Rotterdam, Netherlands., Kroese K; Pan Cancer T BV, Rotterdam, Netherlands., Timmermans MM; Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Zuid Holland, Netherlands., Liao CY; Leiden University, Leiden, Netherlands., Huang S; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Trapman-Jansen A; Erasmus MC Cancer Institute, Rotterdam, Zuid Holland, Netherlands., Foekens R; Erasmus MC, Rotterdam, The Netherlands, Rotterdam, Netherlands., Michaux J; University Hospital of Lausanne, Lausanne, Switzerland., de Beijer MTA; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Buschow SI; Erasmus MC, Rotterdam, Netherlands., Demmers JA; Erasmus MC, Rotterdam, Netherlands., Kok M; Netherlands Cancer Institute, Amsterdam, Netherlands., Danen EH; Leiden University, Leiden, Netherlands., Bassani-Sternberg M; University Hospital of Lausanne, Lausanne, Switzerland., Martens JWM; Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Abbott RJM; Pan Cancer T B.V., Rotterdam, Netherlands., Debets R; Erasmus MC Cancer Institute, Rotterdam, Zuid-Holland, Netherlands.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Aug 22. Date of Electronic Publication: 2024 Aug 22.
IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer.
Autor:
Zhang Y; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands. y.zhang@lacdr.leidenuniv.nl., Wester L; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., He J; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., Geiger T; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Moerkens M; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., Siddappa R; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., Helmijr JA; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands., Timmermans MM; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands., Look MP; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands., van Deurzen CHM; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands.; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands., Pont C; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., de Graauw M; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., Danen EHJ; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., Berns EMJJ; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands., Meerman JHN; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., Jansen MPHM; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands., van de Water B; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands. b.water@lacdr.leidenuniv.nl.
Publikováno v:
Oncogene [Oncogene] 2018 Apr; Vol. 37 (14), pp. 1869-1884. Date of Electronic Publication: 2018 Jan 22.
Autor:
van der Willik KD; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Timmermans MM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., van Deurzen CH; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical CenterRotterdam, The Netherlands; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical CenterRotterdam, The Netherlands., Look MP; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Reijm EA; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., van Zundert WJ; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Foekens R; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Trapman-Jansen AM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., den Bakker MA; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical CenterRotterdam, The Netherlands; Department of Pathology, Maasstad HospitalRotterdam, The Netherlands., Westenend PJ; Laboratory for Pathology Dordrecht, The Netherlands., Martens JW; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Berns EM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Jansen MP; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
Publikováno v:
American journal of cancer research [Am J Cancer Res] 2016 Jan 15; Vol. 6 (2), pp. 270-84. Date of Electronic Publication: 2016 Jan 15 (Print Publication: 2016).
Autor:
Jansen MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands. Electronic address: m.p.h.m.jansen@erasmusmc.nl., Sas L; Translational Cancer Research Unit, GZA Hospitals St-Augustinus, Oosterveldlaan 24, Antwerp B2610, Belgium; Department of Medical Oncology, University Hospital Antwerp, Wilrijkstraat 10, B2650 Antwerp, Belgium., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands., Van Cauwenberghe C; Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Institute Born-Bunge, University of Antwerp, Antwerp, Belgium., Ramirez-Ardila D; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands., Look M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands., Ruigrok-Ritstier K; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands., Finetti P; Marseille Cancer Research Center (CRCM), UMR891 Inserm, Institut Paoli-Calmettes (IPC), Department of Molecular Oncology, Marseille, France., Bertucci F; Marseille Cancer Research Center (CRCM), UMR891 Inserm, Institut Paoli-Calmettes (IPC), Department of Molecular Oncology, Marseille, France., Timmermans MM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands., van Deurzen CH; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands., Simon I; Research and Development, Agendia BV, Amsterdam, The Netherlands., Roepman P; Research and Development, Agendia BV, Amsterdam, The Netherlands., Linn SC; The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Dam P; Translational Cancer Research Unit, GZA Hospitals St-Augustinus, Oosterveldlaan 24, Antwerp B2610, Belgium., Kok M; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lardon F; Department of Medical Oncology, University Hospital Antwerp, Wilrijkstraat 10, B2650 Antwerp, Belgium., Vermeulen PB; Translational Cancer Research Unit, GZA Hospitals St-Augustinus, Oosterveldlaan 24, Antwerp B2610, Belgium., Foekens JA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands., Dirix L; Translational Cancer Research Unit, GZA Hospitals St-Augustinus, Oosterveldlaan 24, Antwerp B2610, Belgium., Berns EM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands., Van Laere S; Translational Cancer Research Unit, GZA Hospitals St-Augustinus, Oosterveldlaan 24, Antwerp B2610, Belgium; Department of Oncology, KU Leuven, Leuven, Belgium.
Publikováno v:
Molecular oncology [Mol Oncol] 2015 Jun; Vol. 9 (6), pp. 1218-33. Date of Electronic Publication: 2015 Mar 04.
Autor:
Onstenk W; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands. w.onstenk@erasmusmc.nl., Kraan J; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Mostert B; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Timmermans MM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Charehbili A; Department of Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands. Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Smit VT; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Kroep JR; Department of Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Nortier JW; Department of Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands., van de Ven S; Department of Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Heijns JB; Department of Medical Oncology, Amphia Hospital, Breda, the Netherlands., Kessels LW; Department of Internal Medicine, Deventer Hospital, Deventer, the Netherlands., van Laarhoven HW; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Bos MM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, the Netherlands., van de Velde CJ; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Gratama JW; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Sieuwerts AM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Martens JW; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Foekens JA; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Sleijfer S; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2015 Mar; Vol. 14 (3), pp. 821-7. Date of Electronic Publication: 2014 Dec 31.